Skip to main content
Top
Published in: Supportive Care in Cancer 3/2019

Open Access 01-03-2019 | Original Article

Criterion for trismus in head and neck cancer patients: a verification study

Authors: Sarah J. van der Geer, Phillip V. van Rijn, Jolanda I. Kamstra, Jan L. N. Roodenburg, Pieter U. Dijkstra

Published in: Supportive Care in Cancer | Issue 3/2019

Login to get access

Abstract

Purpose

Several cut-off points for trismus in head and neck cancer patients have been used. A mouth opening of 35 mm or less is most frequently used as cut-off point. Due to the variation in cut-off points, prevalence, risk factors and treatment outcomes of trismus cannot be studied in a uniform manner. To provide uniformity, we aimed to verify the cut-off point of 35 mm or less. Additionally, we aimed to determine associated covariates with reported difficulties when opening the mouth.

Methods

In a cross-sectional design, we measured the mouth opening in 671 head and neck cancer patients at the Department of Oral and Maxillofacial Surgery, at the University Medical Center Groningen. The cut-off point was determined using the receiver operating characteristic curve and Youden index, with reported difficulties when opening the mouth as criterion for trismus. Cut-off points for significant covariates were also determined.

Results

The Youden index was highest at 35 mm, with a sensitivity of 0.71 and a specificity of 0.86. Of the covariates analysed, type of treatment modality was significantly associated with reported difficulties when opening the mouth. The highest Youden index for patients treated with surgery alone was 37 mm and for patients treated with radiotherapy alone 33 mm.

Conclusions

The cut-off point of 35 mm or less for trismus was confirmed in a head and neck cancer population and is recommended to be used in future studies. Patients receiving different treatment modalities experience difficulty when opening the mouth differently.
Appendix
Available only for authorised users
Literature
1.
go back to reference Weber C, Dommerich S, Pau HW, Kramp B (2010) Limited mouth opening after primary therapy of head and neck cancer. Oral Maxillofac Surg 14:169–173CrossRefPubMed Weber C, Dommerich S, Pau HW, Kramp B (2010) Limited mouth opening after primary therapy of head and neck cancer. Oral Maxillofac Surg 14:169–173CrossRefPubMed
2.
go back to reference Louise Kent M, Brennan MT, Noll JL, Fox PC, Burri SH, Hunter JC, Lockhart PB (2008) Radiation-induced trismus in head and neck cancer patients. Support Care Cancer 16:305–309CrossRefPubMed Louise Kent M, Brennan MT, Noll JL, Fox PC, Burri SH, Hunter JC, Lockhart PB (2008) Radiation-induced trismus in head and neck cancer patients. Support Care Cancer 16:305–309CrossRefPubMed
3.
go back to reference Van Cann EM, Dom M, Koole R, Merkx MA, Stoelinga PJ (2005) Health related quality of life after mandibular resection for oral and oropharyngeal squamous cell carcinoma. Oral Oncol 41:687–693CrossRefPubMed Van Cann EM, Dom M, Koole R, Merkx MA, Stoelinga PJ (2005) Health related quality of life after mandibular resection for oral and oropharyngeal squamous cell carcinoma. Oral Oncol 41:687–693CrossRefPubMed
4.
go back to reference Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT, Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) (2010) A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 18:1033–1038CrossRefPubMed Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT, Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) (2010) A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 18:1033–1038CrossRefPubMed
5.
go back to reference Melchers LJ, Van Weert E, Beurskens CHG, Reintsema H, Slagter AP, Roodenburg JLN, Dijkstra PU (2009) Exercise adherence in patients with trismus due to head and neck oncology: a qualitative study into the use of the Therabite®. Int J Oral Maxillofac Surg 38:947–954CrossRefPubMed Melchers LJ, Van Weert E, Beurskens CHG, Reintsema H, Slagter AP, Roodenburg JLN, Dijkstra PU (2009) Exercise adherence in patients with trismus due to head and neck oncology: a qualitative study into the use of the Therabite®. Int J Oral Maxillofac Surg 38:947–954CrossRefPubMed
6.
go back to reference Lindblom U, Garskog O, Kjellen E, Laurell G, Levring Jaghagen E, Wahlberg P, Zackrisson B, Nilsson P (2014) Radiation-induced trismus in the ARTSCAN head and neck trial. Acta Oncol 53:620–627CrossRefPubMed Lindblom U, Garskog O, Kjellen E, Laurell G, Levring Jaghagen E, Wahlberg P, Zackrisson B, Nilsson P (2014) Radiation-induced trismus in the ARTSCAN head and neck trial. Acta Oncol 53:620–627CrossRefPubMed
7.
go back to reference Steiner F, Evans J, Marsh R, Rigby P, James S, Sutherland K, Wickens R, Nedev N, Kelly B, Tan ST (2015) Mouth opening and trismus in patients undergoing curative treatment for head and neck cancer. Int J Oral Maxillofac Surg 44:292–296CrossRefPubMed Steiner F, Evans J, Marsh R, Rigby P, James S, Sutherland K, Wickens R, Nedev N, Kelly B, Tan ST (2015) Mouth opening and trismus in patients undergoing curative treatment for head and neck cancer. Int J Oral Maxillofac Surg 44:292–296CrossRefPubMed
9.
go back to reference Ozyar E, Cengiz M, Gurkaynak M, Atahan IL (2005) Trismus as a presenting symptom in nasopharyngeal carcinoma. Radiother Oncol 77:73–76CrossRefPubMed Ozyar E, Cengiz M, Gurkaynak M, Atahan IL (2005) Trismus as a presenting symptom in nasopharyngeal carcinoma. Radiother Oncol 77:73–76CrossRefPubMed
10.
go back to reference Kamstra JI, Dijkstra PU, van Leeuwen M, Roodenburg JL, Langendijk JA (2015) Mouth opening in patients irradiated for head and neck cancer: a prospective repeated measures study. Oral Oncol 51:548–555CrossRefPubMed Kamstra JI, Dijkstra PU, van Leeuwen M, Roodenburg JL, Langendijk JA (2015) Mouth opening in patients irradiated for head and neck cancer: a prospective repeated measures study. Oral Oncol 51:548–555CrossRefPubMed
11.
go back to reference Wetzels JW, Merkx MA, de Haan AF, Koole R, Speksnijder CM (2014) Maximum mouth opening and trismus in 143 patients treated for oral cancer: a 1-year prospective study. Head Neck 36:1754–1762CrossRefPubMed Wetzels JW, Merkx MA, de Haan AF, Koole R, Speksnijder CM (2014) Maximum mouth opening and trismus in 143 patients treated for oral cancer: a 1-year prospective study. Head Neck 36:1754–1762CrossRefPubMed
12.
go back to reference Gebre-Medhin M, Haghanegi M, Robert L, Kjellen E, Nilsson P (2016) Dose-volume analysis of radiation-induced trismus in head and neck cancer patients. Acta Oncol 55:1313–1317CrossRefPubMed Gebre-Medhin M, Haghanegi M, Robert L, Kjellen E, Nilsson P (2016) Dose-volume analysis of radiation-induced trismus in head and neck cancer patients. Acta Oncol 55:1313–1317CrossRefPubMed
13.
go back to reference Dijkstra PU, Huisman PM, Roodenburg JLN (2006) Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 35:337–342CrossRefPubMed Dijkstra PU, Huisman PM, Roodenburg JLN (2006) Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 35:337–342CrossRefPubMed
14.
go back to reference Scott B, Butterworth C, Lowe D, Rogers SN (2008) Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a maxillofacial oncology clinic. Oral Oncol 44:430–438CrossRefPubMed Scott B, Butterworth C, Lowe D, Rogers SN (2008) Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a maxillofacial oncology clinic. Oral Oncol 44:430–438CrossRefPubMed
16.
go back to reference Schisterman EF, Perkins NJ, Liu A, Bondell H (2005) Optimal cut-point and its corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology 16:73–81CrossRefPubMed Schisterman EF, Perkins NJ, Liu A, Bondell H (2005) Optimal cut-point and its corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology 16:73–81CrossRefPubMed
17.
go back to reference Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY (2005) The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115:1458–1460CrossRefPubMed Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY (2005) The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115:1458–1460CrossRefPubMed
18.
go back to reference Nagaraja S, Kadam SA, Selvaraj K, Ahmed I, Javarappa R (2016) Trismus in head and neck cancer patients treated by telecobalt and effect of early rehabilitation measures. J Cancer Res Ther 12:685–688CrossRefPubMed Nagaraja S, Kadam SA, Selvaraj K, Ahmed I, Javarappa R (2016) Trismus in head and neck cancer patients treated by telecobalt and effect of early rehabilitation measures. J Cancer Res Ther 12:685–688CrossRefPubMed
19.
go back to reference Jager-Wittenaar H, Dijkstra PU, Vissink A, van Oort RP, Roodenburg JLN (2009) Variation in repeated mouth-opening measurements in head and neck cancer patients with and without trismus. Int J Oral Maxillofac Surg 38:26–30CrossRefPubMed Jager-Wittenaar H, Dijkstra PU, Vissink A, van Oort RP, Roodenburg JLN (2009) Variation in repeated mouth-opening measurements in head and neck cancer patients with and without trismus. Int J Oral Maxillofac Surg 38:26–30CrossRefPubMed
Metadata
Title
Criterion for trismus in head and neck cancer patients: a verification study
Authors
Sarah J. van der Geer
Phillip V. van Rijn
Jolanda I. Kamstra
Jan L. N. Roodenburg
Pieter U. Dijkstra
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4402-z

Other articles of this Issue 3/2019

Supportive Care in Cancer 3/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine